Considering Patient Preferences When Selecting Anti–Tumor Necrosis Factor Therapeutic Options

BACKGROUND: Anti–tumor necrosis factor (TNF) medications for the treatment of chronic inflammatory conditions represent a large and growing expenditure for health plans. Over the past few years, there has been an increase in options for patients receiving anti-TNFs, including choice of agent, route...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Sylwestrzak, Gosia, Liu, Jinan, Stephenson, Judith J., Ruggieri, Alexander P., DeVries, Andrea
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Engage Healthcare Communications, LLC 2014
Konular:
Clinical
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4049117/
https://ncbi.nlm.nih.gov/pubmed/24991392
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller